Marcus Padley asks readers for 'stupid questions' and, he says, "I get them." Like: "I have $10,000 and want to turn it into $1 million. How do I do it?"
Shares
Macquarie Securities, the broking arm of Macquarie Group, is under fire for allegedly misreporting millions of trades over 14 years.
What do Harley-Davidson and Sotheby's have in common? Their stocks have clever ticker symbols, and these small codes can have a big impact.
In 2015 Warren Buffett's Berkshire Hathaway took a stake in Insurance Australia Group. That deal didn't go the distance, but could it return? Without a doubt.
The arrival of weight-loss drugs like Ozempic rattled ResMed shareholders but so far the fear has been misplaced, writes Jun Bei Liu.
There's growing speculation that the RBA will cut interest rates in May. In fact, CBA has gone as far as calling it a 'done deal'. But is that optimism premature?
There were more than twice as many delistings as listings on the ASX in 2024, so what happens when a stock is delisted?
Donald Trump's latest tariff bombshell has shaken global markets and it's raising serious questions. Was this chaos just bad policy or something more calculated?
Headquartered in Auckland, Fisher & Paykel Healthcare has translated its robust sales growth into even stronger earnings growth.
Donald Trump's latest wave of global import tariffs is sending shockwaves throughout world economies, drawing comparisons to the infamous Smoot-Hawley Tariff Act of the 1930s.
